- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Senate passes Drug Quality and Security Act
- Walgreens Infusion Services can save $10.8 million in healthcare costs annually
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
INDIANAPOLIS — Lilly Diabetes and Walgreens on Monday launched an awareness campaign at 43 Walgreens pharmacies throughout the Indianapolis area on the consequences of hypoglycemia.
"At Lilly Diabetes, we understand that managing diabetes extends beyond medicines to tools and resources that provide real, personalized solutions to improve the quality of everyday life," stated Steve Sugino, VP Lilly Diabetes. "This initiative will not only provide needed education, but will also ultimately help facilitate better discussions between pharmacists and people with diabetes that can lead to improved disease management."
The Lilly Diabetes-Walgreens approach is designed to complement the care and guidance people with diabetes receive from their healthcare providers. The campaign will be launched in 43 Walgreens stores in the Indianapolis area and will showcase Walgreens' new approach to community pharmacy that includes making pharmacists more accessible for patient consultations. Based on customer feedback over the next six months, the companies will explore expanding the campaign in additional cities.